Ambu A/S (AMBBY)
10.16
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Ambu Enterprise Value : 2.339B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 2.339B |
| June 08, 2026 | 2.339B |
| June 05, 2026 | 2.339B |
| June 04, 2026 | 2.339B |
| June 03, 2026 | 2.339B |
| June 02, 2026 | 2.339B |
| June 01, 2026 | 2.339B |
| May 29, 2026 | 2.339B |
| May 28, 2026 | 2.347B |
| May 27, 2026 | 2.677B |
| May 26, 2026 | 2.677B |
| May 22, 2026 | 2.677B |
| May 21, 2026 | 2.677B |
| May 20, 2026 | 2.677B |
| May 19, 2026 | 2.511B |
| May 18, 2026 | 2.511B |
| May 15, 2026 | 2.511B |
| May 14, 2026 | 2.567B |
| May 13, 2026 | 2.567B |
| May 12, 2026 | 2.567B |
| May 11, 2026 | 2.567B |
| May 08, 2026 | 2.621B |
| May 07, 2026 | 2.624B |
| May 06, 2026 | 2.624B |
| May 05, 2026 | 2.802B |
| Date | Value |
|---|---|
| May 04, 2026 | 2.802B |
| May 01, 2026 | 2.802B |
| April 30, 2026 | 2.802B |
| April 29, 2026 | 2.802B |
| April 28, 2026 | 2.802B |
| April 27, 2026 | 2.802B |
| April 24, 2026 | 2.802B |
| April 23, 2026 | 2.802B |
| April 22, 2026 | 2.802B |
| April 21, 2026 | 2.895B |
| April 20, 2026 | 2.895B |
| April 17, 2026 | 2.895B |
| April 16, 2026 | 2.773B |
| April 15, 2026 | 2.682B |
| April 14, 2026 | 2.682B |
| April 13, 2026 | 2.682B |
| April 10, 2026 | 2.682B |
| April 09, 2026 | 2.682B |
| April 08, 2026 | 2.629B |
| April 07, 2026 | 2.629B |
| April 06, 2026 | 2.781B |
| April 02, 2026 | 2.781B |
| April 01, 2026 | 2.781B |
| March 31, 2026 | 2.713B |
| March 30, 2026 | 2.707B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Coloplast A/S | 16.22B |
| Enovis Corp. | 2.759B |
| Edwards Lifesciences Corp. | 47.54B |
| IDEXX Laboratories, Inc. | 46.78B |
| Intuitive Surgical, Inc. | 146.77B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 18.95M |
| Revenue (Quarterly) | 246.33M |
| Total Expenses (Quarterly) | 227.38M |
| EPS Diluted (Quarterly) | 0.0711 |
| Gross Profit Margin (Quarterly) | 60.27% |
| Profit Margin (Quarterly) | 7.69% |
| Earnings Yield | 2.73% |
| Operating Earnings Yield | 3.74% |
| Normalized Earnings Yield | 2.729 |